M W Kline
Affiliation: Baylor College of Medicine
- Long-term follow-up of 414 HIV-infected Romanian children and adolescents receiving lopinavir/ritonavir-containing highly active antiretroviral therapyMark W Kline
Baylor College of Medicine International Pediatric AIDS Initiative, Texas Children s Hospital, Houston, Texas, USA
Pediatrics 119:e1116-20. 2007....
- Comprehensive pediatric human immunodeficiency virus care and treatment in Constanta, Romania: implementation of a program of highly active antiretroviral therapy in a resource-poor settingMark W Kline
Department of Pediatrics, Baylor College of Medicine and Texas Children s Hospital, Houston, TX 77030, USA
Pediatr Infect Dis J 23:695-700. 2004..S. health care institution and the Romanian government, has established a comprehensive program of highly active antiretroviral therapy for children in Constanta, Romania...
- Disparity between pediatricians' knowledge and practices regarding perinatal human immunodeficiency virus counseling and testingMark W Kline
Committee on Pediatric AIDS, American Academy of Pediatrics, Elk Grove Village, Illinois, USA
Pediatrics 112:e367. 2003....
- Combination therapy with saquinavir soft gelatin capsules in children with human immunodeficiency virus infectionM W Kline
Department of Pediatrics, Baylor College of Medicine and Texas Children s Hospital, Houston 77030, USA
Pediatr Infect Dis J 20:666-71. 2001....
- Pilot study of hydroxyurea in human immunodeficiency virus-infected children receiving didanosine and/or stavudineM W Kline
Department of Pediatrics, Baylor College of Medicne, Texas Children s Hospital, Houston 77030, USA
Pediatr Infect Dis J 19:1083-6. 2000..To evaluate the safety and antiviral and immunologic effects of hydroxyurea given with didanosine (ddI) and/or stavudine (d4T) to symptomatic HIV-infected children...
- Isolation of Lautropia mirabilis from oral cavities of human immunodeficiency virus-infected childrenS N Rossmann
Baylor College of Medicine and Texas Children s Hospital, Houston 77030, USA
J Clin Microbiol 36:1756-60. 1998..mirabilis in immunological status, clinical status, or systemic medications. The role of HIV infection itself or concomitant factors in the establishment of L. mirabilis in the oral cavity remains to be elucidated...
- Recombinant human gamma interferon in human immunodeficiency virus-infected children: safety, CD4(+)-lymphocyte count, viral load, and neutrophil function (AIDS Clinical Trials Group Protocol 211)W T Shearer
Departments of Pediatrics and Microbiology and Immunology, Baylor College of Medicine, Texas Children s Hospital, Houston 77030, USA
Clin Diagn Lab Immunol 6:311-5. 1999....
- Transport of recombinant human CD4-immunoglobulin G across the human placenta: pharmacokinetics and safety in six mother-infant pairs in AIDS clinical trial group protocol 146W T Shearer
Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA
Clin Diagn Lab Immunol 2:281-5. 1995..In summary, these findings document that bifunctional immune molecules can be transported across the placenta, and this general approach may be used in the future to block vertical transmission of HIV type 1...
- Dental caries in HIV-infected children: a longitudinal studyM J Hicks
Department of Pathology, Baylor College of Medicine, USA
Pediatr Dent 22:359-64. 2000....
- Oral manifestations of pediatric vertical HIV infectionC A Kozinetz
Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA
AIDS Patient Care STDS 14:89-94. 2000..Oral manifestations are significant clinical outcomes in pediatric vertical HIV infection, particularly for children diagnosed previously with an oral manifestation...
- Citrobacter diversus and neonatal brain abscessM W Kline
Myers Black Section of Pediatric Infectious Diseases, Baylor College of Medicine and Texas Children s Hospital, Houston 77030
Pediatr Neurol 3:178-80. 1987..A high prevalence of brain abscess mandates cranial computed tomography for any infant with C. diversus meningitis...
- No greater gift than hopeMark W Kline
Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA
Semin Pediatr Infect Dis 14:309-13. 2003
- Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infectionWalter T Hughes
Department of Infectious Diseases, St Jude Children s Research Hospital, Memphis, TN 38105 2794, USA
Clin Infect Dis 40:136-45. 2005....
- Longitudinal study of the prevalence and prognostic implications of oral manifestations in romanian children infected with human immunodeficiency virus type 1Nicoleta Vaseliu
Romanian American Children s Center, Constanta, Romania
Pediatr Infect Dis J 24:1067-71. 2005..We evaluated the prevalence and predictive value for human immunodeficiency virus (HIV) disease progression of oral manifestations in Romanian children...
- Influence of institutionalization on time to HIV disease progression in a cohort of Romanian children and teensMargaret Ferris
Baylor College of Medicine, Department of Pediatrics, 6621 Fannin St, CCC1210, Houston, TX 77030, USA
Pediatrics 120:e1476-80. 2007..The purpose of this work was to investigate the effect of institutionalization on death and CD4 decline in a cohort of 325 HIV-infected Romanian children...
- Disseminated Acanthamoeba infection in a human immunodeficiency virus-infected infantHeidi Schwarzwald
Department of Pediatrics, Baylor College of Medicine and Texas Children s Hospital, Houston, 77030, USA
Pediatr Infect Dis J 22:197-9. 2003..We present the first case of disseminated Acanthamoeba infection in an HIV-infected infant. The infant survived 2 years with treatment with several agents having anti-Acanthamoeba activity in vitro...
- False negative DNA polymerase chain reaction in an infant with subtype C human immunodeficiency virus 1 infectionNancy E Kline
Section of Retrovirology, Department of Pediatrics, Baylor College of Medicine and Texas Children s Hospital, Houston, TX 77030, USA
Pediatr Infect Dis J 21:885-6. 2002..Clinicians should be aware of this particular limitation of HIV DNA PCR assays, because it is likely that an increasing proportion of the HIV-infected infants seen in US centers will be infected with non-subtype B HIV...
- Efavirenz liquid formulation in human immunodeficiency virus-infected childrenStuart E Starr
Division of Infectious and Immunologic Diseases, Abramson Research Center, The Children s Hospital of Philadelphia, PA 19104, USA
Pediatr Infect Dis J 21:659-63. 2002....
- Magnitude of IFN-gamma production in HIV-1-infected children is associated with virus suppressionJames M Reuben
Department of Hematopathology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
J Allergy Clin Immunol 110:255-61. 2002..Little is known about the cytokine production by peripheral blood cells of pediatric patients who have suppressed HIV-1 replication after highly active antiretroviral therapy (HAART)...
- Growth in HIV-infected children receiving antiretroviral therapy at a pediatric infectious diseases clinic in UgandaMark M Kabue
Baylor College of Medicine, Abbott Fund Children s Clinical Centre of Excellence, Malawi
AIDS Patient Care STDS 22:245-51. 2008..001). Weight-for-age percentile and z score improved significantly after initiation of ART. This pediatric population gained weight more rapidly than height after initiation of ART...
- Pharmacokinetics and pharmacodynamics of saquinavir in pediatric patients with human immunodeficiency virus infectionSibylle Grub
F Hoffmann La Roche Ltd, Basel, Switzerland
Clin Pharmacol Ther 71:122-30. 2002....
- Selection of zidovudine resistance mutations and escape of human immunodeficiency virus type 1 from antiretroviral pressure in stavudine-treated pediatric patientsHorst Guenter Maxeiner
Department of Virology, University Medical Center, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
J Infect Dis 185:1070-6. 2002..The effect of these mutations on phenotypic stavudine susceptibility is relatively small but apparently large enough to be clinically significant...
- Perspectives on the pediatric HIV/AIDS pandemic: catalyzing access of children to care and treatmentMark W Kline
The Baylor International Pediatric AIDS Initiative, Department of Pediatrics, Baylor College of Medicine, Texas Children s Hospital, Houston, Texas, USA
Pediatrics 117:1388-93. 2006....
- Pediatric and adult HIV/AIDS treatment: still worlds apartMark W Kline
Baylor College of Medicine and Texas Children s Hospital, Houston, Texas, USA
Res Initiat Treat Action 11:22-3. 2005
- A simplified weight-based method for pediatric drug dosing for zidovudine and didanosine in resource-limited settingsPaul J Weidle
Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Pediatr Infect Dis J 25:59-64. 2006..Although weight and height can both be measured, it may be impractical to expect providers in resource-limited settings to estimate accurately body surface area...
- Editorial comment: challenges to pediatric adherence to antiretroviral medicationsMeg Gwynne Ferris
AIDS Read 12:162-3. 2002
- High prevalence of hepatitis B virus markers in Romanian adolescents with human immunodeficiency virus infectionSimona Maria Ruta
Stefan S Nicolau Institute of Virology, Bucharest, Romania
MedGenMed 7:68. 2005..We evaluated the frequency of hepatitis coinfection in Romanian adolescents who were diagnosed with human immunodeficiency virus (HIV) infection prior to 1995...
- Treatment of human immunodeficiency virus (HIV) in children using antiretroviral drugsGabriel Misango Anabwani
Department of Paediatrics, Baylor College of Medicine and Texas Children s Hospital, Houston, USA
Semin Pediatr Infect Dis 16:116-24. 2005....
- Lipodystrophy syndrome in human immunodeficiency virus-infected childrenRene A Amaya
Department of Pediatrics, Baylor College of Medicine, Texas Children s Hospital, Houston, USA
Pediatr Infect Dis J 21:405-10. 2002..Many studies suggest that antiretroviral therapy is the underlying cause of the condition. Few data exist for HIV-infected children...
- Human immunodeficiency virus protease inhibitorsMark W Kline
Baylor College of Medicine and Texas Children s Hospital, Houston, USA
Pediatr Infect Dis J 22:1085-7. 2003
- Pharmacokinetics of saquinavir in children during long term treatmentSibylle Grub
Pediatr Infect Dis J 21:712-3. 2002
- Education and preparation of physicians entering an international pediatric AIDS program: the Pediatric AIDS CorpsGordon E Schutze
Department of Pediatrics, Baylor College of Medicine, Baylor International Pediatric AIDS Initiative, Houston, TX 77030, USA
AIDS Patient Care STDS 22:709-14. 2008..The foundation provided by this educational course was an important beginning for the PAC physicians. Other groups providing specialized care to patients in developing countries might consider a similar educational program...